Search results for "neurotrophic factors"

showing 10 items of 88 documents

Microtubule Dynamics and Neuronal Excitability: Advances on Cytoskeletal Components Implicated in Epileptic Phenomena

2020

AbstractExtensive researches have deepened knowledge on the role of synaptic components in epileptogenesis, but limited attention has been devoted to the potential implication of the cytoskeleton. The study of the development of epilepsy and hyperexcitability states involves molecular, synaptic, and structural alterations of neuronal bioelectric activity. In this paper we aim to explore the neurobiological targets involved in microtubule functioning and cytoskeletal transport, i.e. how dynamic scaffolding of microtubules can influence neuronal morphology and excitability, in order to suggest a potential role for microtubule dynamics in the processes turning a normal neuronal network in a hy…

NeurodevelopmentHyperexcitabilityMicrotubuleBiologyMicrotubulesSettore BIO/09 - FisiologiaEpileptogenesisNeuroprotectionMicrotubule polymerizationCellular and Molecular NeuroscienceNeurotrophic factorsMicrotubulemedicineHumansPremovement neuronal activityCannabinoidCytoskeletonNeuronsEpilepsyNeurodegenerationCell BiologyGeneral Medicinemedicine.diseaseNeuroprotectionMicrotubule-Associated ProteinsNeuroscienceNeural developmentCellular and Molecular Neurobiology
researchProduct

Neurotrophic systems promoting neurogenesis in the adult rat brain

2008

Neurogenesis neurotrophic factors FGF-2Settore BIO/09 - Fisiologia
researchProduct

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depressio…

2011

Abstract In Major Depressive Disorder, a growing data base suggests that the onset of antidepressants’ action can be detected by improvement of depressive symptoms in the first 10–14 days of treatment. Previous studies showed that the mean concentration of the brain-derived neurotrophic factor (BDNF) in blood increases during antidepressant treatment and positively correlates with amelioration of MDD symptoms. We previously showed an association between very early changes of the serum BDNF concentration and treatment outcome ( Tadic et al., 2011 . Prog Neuropsychopharmacol Biol Psychiatry 35, 415–420). However, no study has yet investigated whether BDNF concentration in plasma increases in …

OncologyAdultMalemedicine.medical_specialtyTime FactorsEnzyme-Linked Immunosorbent AssayCellular and Molecular NeuroscienceYoung AdultNeurotrophic factorsInternal medicineHamdmedicineHumansPsychiatryDepression (differential diagnoses)PharmacologyBrain-derived neurotrophic factorPsychiatric Status Rating ScalesDepressive Disorder MajorInpatientsBrain-Derived Neurotrophic FactorMiddle Agedmedicine.diseaseAntidepressive AgentsROC CurveLinear ModelsAntidepressantBiomarker (medicine)Major depressive disorderAnxietyFemalemedicine.symptomPsychologyNeuropharmacology
researchProduct

Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective…

2012

Brain-derived neurotrophic factor (BDNF) is a neurotrophin that influences neuronal plasticity throughout life. Emergence from a vegetative state (VS) after a traumatic brain injury (TBI) implies that the brain undergoes plastic changes. A common polymorphism in the BDNF gene—BDNF Val66Met (referred to herein as BDNFMet)—impairs cognitive function in healthy subjects. The aim of this study was to determine whether the BDNFMet polymorphism plays a role in the recovery of consciousness and cognitive functions in patients in a VS after a TBI. Fifty-three patients in a VS 1 month after a TBI were included in the study and genotyped for the BDNFMet polymorphism. Scores of levels of cognitive fun…

OncologyAdultMalemedicine.medical_specialtydisorders of consciousneAdolescentGenotypeTraumatic brain injuryPolymorphism Single Nucleotidevegetative stateYoung AdultNeurotrophic factorsInternal medicineNeuroplasticitymedicineHumansYoung adultPsychiatryRetrospective StudiesBrain-derived neurotrophic factorbiologytraumatic brain injuryBrain-Derived Neurotrophic FactorPersistent Vegetative Statelevels of cognitive functioninggenetic factorRetrospective cohort studyCognitionRecovery of FunctionMiddle Agedmedicine.diseasenervous systemBrain Injuriesbiology.proteinFemaleNeurology (clinical)PsychologyPolymorphism Restriction Fragment LengthNeurotrophinJournal of neurotrauma
researchProduct

Brain-derived neurotrophic factor correlates with functional and cognitive impairment in non-disabled older individuals.

2015

We used a complete battery of geriatric and psychometric tests to evaluate whether plasma-borne brain-derived neurotrophic factor (BDNF), a master molecule in neuroplasticity, is associated with the severity of functional and cognitive impairment in non-disabled older individuals. There was a significant positive correlation between BDNF plasma concentrations and the Barthel index, a measurement of the ability of individuals to perform the activities of daily living (p=0.03) and the concentration subcategory measured with the mini mental state examination (MMSE) test (p = 0.01). Furthermore, plasma BDNF inversely and significantly correlated with the blood eosinophil count (p = 0.01), the t…

OncologyMaleAgingmedicine.medical_specialtyActivities of daily livingFrail ElderlyNeuropsychological TestsBiochemistryEndocrinologyCognitionNeurotrophic factorsInternal medicineNeuroplasticityActivities of Daily LivingGeneticsMedicineHumansPsychiatryMolecular BiologyGeriatric AssessmentAgedBrain-derived neurotrophic factorAged 80 and overMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryBrain-Derived Neurotrophic FactorCognitionCell BiologyMiddle AgedPathophysiologyCross-Sectional StudiesSpainLinear ModelsBiomarker (medicine)FemalebusinessCognition DisordersBiomarkersExperimental gerontology
researchProduct

The Utility of BDNF Detection in Assessing Severity of Huntington's Disease.

2021

Brain-derived neurotrophic factor (BDNF) is involved in the survival and maturation of neurons, and also promotes and controls neurogenesis. Its levels are lowered in many neurodegenerative diseases, including Huntington’s disease (HD). Clinical pictures of HD can be very diverse, which makes it difficult to assess its severity

Oncologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryNeurogenesisRNeurological examinationGeneral MedicineDiseasemedicine.diseaseMotor symptomsArticleBDNFHuntington's diseasenervous systemNeurotrophic factorsInternal medicineHealthy volunteersmedicineMedicinedisease severitybusinessCognitive impairmentHuntington’s diseaseJournal of clinical medicine
researchProduct

Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myoca…

2009

Little is known about the role of neurotrophins (NT) under adult vascular homeostasis in normal and pathological conditions. The NT family, including nerve growth factor and brain-derived neurotrophic factor (BDNF) are expressed in atherosclerotic vessels. Previous studies demonstrated that plasma BDNF levels were increased in the coronary circulation in patients with unstable angina. However, the role of BDNF during the onset and evolution of unstable angina remains to be elucidated. The objective of this study was to evaluate the relationship between BDNF, functional parameters and biological markers associated with inflammatory processes and platelet activation. BDNF serum levels were as…

PharmacologyBrain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyP-selectinUnstable anginabusiness.industry030204 cardiovascular system & hematologymedicine.disease03 medical and health sciencesCoronary circulation0302 clinical medicineNerve growth factorEndocrinologymedicine.anatomical_structureNeurotrophic factorsInternal medicineImmunologymedicinePharmacology (medical)Platelet activationMyocardial infarctionbusiness030304 developmental biologyFundamental & Clinical Pharmacology
researchProduct

A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors.

2003

Recent evidence indicates that trophic factors can exert fast effects on neurones and so alter synaptic plasticity. Here, we focus on brain-derived neurotrophic factor (BDNF), which exerts a modulatory action at hippocampal synapses that are involved in learning and memory, and at the first pain synapse between primary sensory neurones and dorsal horn neurones. Hippocampal and sensory neurones share some properties for the release of endogenous BDNF. In the Schaffer collateral pathway of the hippocampus, binding of BDNF to high-affinity trkB receptors is essential for the induction of long-term potentiation, a specific type of synaptic plasticity. However, the consequences of BDNF binding t…

PharmacologyBrain-derived neurotrophic factorBrain-Derived Neurotrophic FactorPainLong-term potentiationTropomyosin receptor kinase BToxicologyHippocampusSynapsemedicine.anatomical_structurenervous systemSchaffer collateralNeurotrophic factorsMemorySynaptic plasticityMetaplasticitySynapsesmedicineHumansReceptor trkBNeurons AfferentPsychologyNeuroscienceTrends in pharmacological sciences
researchProduct

Nicotinic receptors and neurotrophic factors

2000

PharmacologybiologyNicotinic ReceptorsChemistryTropomyosin receptor kinase BCiliary neurotrophic factorCell biologyPsychiatry and Mental healthNeurologyNeurotrophic factorsbiology.proteinGlial cell line-derived neurotrophic factorPharmacology (medical)Neurology (clinical)Biological PsychiatryEuropean Neuropsychopharmacology
researchProduct

Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynor…

2021

Delayed onset of antidepressant action is a shortcoming in depression treatment. Ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) have emerged as promising rapid-acting antidepressants. However, their mechanism of action remains unknown. In this study, we first described the anxious and depression-prone inbred mouse strain, DBA/2J, as an animal model to assess the antidepressant-like effects of ketamine and HNK in vivo. To decode the molecular mechanisms mediating HNK's rapid antidepressant effects, a longitudinal cerebrospinal fluid (CSF) proteome profiling of its acute and sustained effects was conducted using an unbiased, hypothesis-free mass spectrometry-based proteomics app…

ProteomicsNeurophysiology and neuropsychologyanimal structuresHydroxynorketaminePhysiologyGlucocorticoid receptor signalingAntidepressantCSFNeurosciences. Biological psychiatry. NeuropsychiatryBiologyPharmacologyProteomicsBiochemistryCellular and Molecular NeuroscienceEndocrinologyGlucocorticoid receptorNeurotrophic factorsmedicineOriginal Research ArticleKetamine ; CSF ; Antidepressant ; (2R6R)-Hydroxynorketamine ; Glucocorticoid receptor signaling ; ProteomicsRC346-429Molecular BiologyPI3K/AKT/mTOR pathwayEndocrine and Autonomic SystemsQP351-495Mechanism of action(2R6R)-Hydroxynorketamineembryonic structuresAntidepressantKetamineNeurology. Diseases of the nervous systemmedicine.symptomSignal transductionRC321-571Neurobiology of Stress
researchProduct